Skip to main content
Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · IEX Real-Time Price · USD
7.42
+0.40 (5.70%)
At close: May 31, 2024, 4:00 PM
7.27
-0.15 (-2.02%)
After-hours: May 31, 2024, 5:46 PM EDT

Travere Therapeutics Revenue

Travere Therapeutics had revenue of $183.23M in the twelve months ending March 31, 2024, with 28.61% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $41.37M with 33.95% year-over-year growth. In the year 2023, Travere Therapeutics had annual revenue of $145.24M with 32.69% growth.

Revenue (ttm)
$183.23M
Revenue Growth
+28.61%
P/S Ratio
3.08
Revenue / Employee
$482,171
Employees
380
Market Cap
564.88M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023145.24M35.78M32.69%
Dec 31, 2022109.46M-22.38M-16.97%
Dec 31, 2021131.84M-66.49M-33.52%
Dec 31, 2020198.32M22.98M13.11%
Dec 31, 2019175.34M11.09M6.75%
Dec 31, 2018164.25M9.31M6.01%
Dec 31, 2017154.94M21.35M15.98%
Dec 31, 2016133.59M33.70M33.74%
Dec 31, 201599.89M71.69M254.19%
Dec 31, 201428.20M--
Dec 31, 20130--
Dec 31, 20120--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Accolade 414.29M
SI-BONE 144.05M
Surmodics 142.96M
Heron Therapeutics 132.10M
Zymeworks 50.46M
EyePoint Pharmaceuticals 50.02M
Revenue Rankings

TVTX News

More News